134 related articles for article (PubMed ID: 36990733)
21. Terminal deoxynucleotidyl transferase (TdT)-positive cells in cerebrospinal fluid and development of overt CNS leukemia: a 5-year follow-up study in 113 children with a TdT-positive leukemia or non-Hodgkin's lymphoma.
Hooijkaas H; Hählen K; Adriaansen HJ; Dekker I; van Zanen GE; van Dongen JJ
Blood; 1989 Jul; 74(1):416-22. PubMed ID: 2752121
[TBL] [Abstract][Full Text] [Related]
22. [Terminal deoxynucleotidyl transferase (TdT)].
Sasaki R
Nihon Rinsho; 2004 Dec; 62 Suppl 12():815-9. PubMed ID: 15658458
[No Abstract] [Full Text] [Related]
23. Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia.
Yu CH; Su YH; Jou ST; Lu MY; Lin CY; Lin KH; Chang HH; Chou SW; Huang YH; Lin DT; Lin SW; Chen HY; Chang YH; Yang YL
Pathol Res Pract; 2024 Apr; 256():155287. PubMed ID: 38579576
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous pre-B lymphoblastic lymphoma immunohistologically mimics Ewing's sarcoma/primitive neuroectodermal tumor.
Hsiao CH; Su IJ
J Formos Med Assoc; 2003 Mar; 102(3):193-7. PubMed ID: 12783138
[TBL] [Abstract][Full Text] [Related]
25. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections.
Orazi A; Cattoretti G; John K; Neiman RS
Mod Pathol; 1994 Jun; 7(5):582-6. PubMed ID: 7937725
[TBL] [Abstract][Full Text] [Related]
26. [Mediastinal T lymphoblastic lymphoma/leukemia: clinicopathological and prognostic analyses of 61 cases].
Gao XZ; Wei JG; Li SL; Han J; Wang GN; Li WC
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):601-606. PubMed ID: 32486538
[No Abstract] [Full Text] [Related]
27. CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease.
Dworzak MN; Fröschl G; Printz D; Zen LD; Gaipa G; Ratei R; Basso G; Biondi A; Ludwig WD; Gadner H
Leukemia; 2004 Apr; 18(4):703-8. PubMed ID: 14961034
[TBL] [Abstract][Full Text] [Related]
28. Ewing sarcoma vs lymphoblastic lymphoma. A comparative immunohistochemical study.
Lucas DR; Bentley G; Dan ME; Tabaczka P; Poulik JM; Mott MP
Am J Clin Pathol; 2001 Jan; 115(1):11-7. PubMed ID: 11190795
[TBL] [Abstract][Full Text] [Related]
29. Terminal deoxynucleotidyl transferase negative B-lymphoblastic leukaemia/lymphoma with CD138 expression.
Lee SY; Hue SS
Pathology; 2020 Feb; 52(2):286-289. PubMed ID: 31883671
[No Abstract] [Full Text] [Related]
30. State of chromosome 11q23 in T-ALL/LBL and their relation to prognosis.
Wang JF; Li J; Xi YF; Bai W
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):375-80. PubMed ID: 22710816
[TBL] [Abstract][Full Text] [Related]
31. Nonpositive terminal deoxynucleotidyl transferase in pediatric precursor B-lymphoblastic leukemia.
Liu L; McGavran L; Lovell MA; Wei Q; Jamieson BA; Williams SA; Dirks NN; Danielson MS; Dubie LM; Liang X
Am J Clin Pathol; 2004 Jun; 121(6):810-5. PubMed ID: 15198352
[TBL] [Abstract][Full Text] [Related]
32. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
33. Immature Terminal Deoxynucleotidyl Transferase Positive B Cells are Detected in a Subset of Adult and Pediatric Liver Biopsies.
Wen KW; Gill RM
Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):319-324. PubMed ID: 28968264
[TBL] [Abstract][Full Text] [Related]
34. Terminal deoxynucleotidyl transferase activity in non-hematologic and hematologic neoplasms.
Castella A; Davey FR; Kurec AS; Thompson NA
Ann Clin Lab Sci; 1982; 12(5):403-7. PubMed ID: 6958214
[TBL] [Abstract][Full Text] [Related]
35. Molecular and phenotypic characterization of an early T-cell precursor acute lymphoblastic lymphoma harboring PICALM-MLLT10 fusion with aberrant expression of B-cell antigens.
Khurana S; Melody ME; Ketterling RP; Peterson JF; Luoma IM; Vazmatzis G; Tun HW; Foran JM; Jiang L
Cancer Genet; 2020 Jan; 240():40-44. PubMed ID: 31739126
[TBL] [Abstract][Full Text] [Related]
36. Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement.
Yoon J; Yun JW; Jung CW; Ju HY; Koo HH; Kim SH; Kim HJ
Genes Chromosomes Cancer; 2020 Apr; 59(4):255-260. PubMed ID: 31705772
[TBL] [Abstract][Full Text] [Related]
37. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
Brar N; Butzmann A; Kumar J; Peerani R; Morgan EA; Grigoriadis G; Kumar B; Tatarczuch RM; Warnke RA; Ohgami RS
Histopathology; 2020 Dec; 77(6):984-988. PubMed ID: 32526041
[TBL] [Abstract][Full Text] [Related]
38. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related diseases.
Zhang PJ; Barcos M; Stewart CC; Block AW; Sait S; Brooks JJ
Mod Pathol; 2000 Apr; 13(4):452-8. PubMed ID: 10786814
[TBL] [Abstract][Full Text] [Related]
39. Transformation of a low-grade follicular lymphoma into a composite lymphoma combining a high-grade B-cell lymphoma and a lymphoblastic neoplasm expressing Terminal deoxynucleotidyl Transferase: a case report.
Bouroumeau A; Kaphan E; Legrand C; Raskovalova T; Szymanski G; Vettier C; Lefebvre C; Jacob MC; McLeer A; Peuchmaur M; Gressin R; Sartelet H
J Med Case Rep; 2020 Jul; 14(1):117. PubMed ID: 32713346
[TBL] [Abstract][Full Text] [Related]
40. Adenosine deaminase and terminal deoxynucleotidyl transferase in human lymphomas: an aid to the diagnosis and subclassification of lymphoblastic lymphomas.
Vezzoni P; Giardini R; Lucchini R; Lombardi L; Vezzoni MA; Besana C; Clerici L
Am J Hematol; 1985 Jul; 19(3):219-27. PubMed ID: 4014222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
